Toward improved understanding of a potential association between isotretinoin and inflammatory bowel disease

Abstract

Isotretinoin is a widely prescribed medication for nodulocystic acne. Existing literature is conflicting regarding an association between isotretinoin and inflammatory bowel disease. In this issue, Alhusayen et al. report findings from a 12-year observational study exploring a possible association, and they conclude that acne itself may be responsible for an apparent correlation. © 2013 The Society for Investigative Dermatology.